Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.

Labidi-Galy SI, de La Motte Rouge T, Derbel O, Wolfer A, Kalbacher E, Olivier T, Combes JD, Heimgartner-Hu K, Tredan O, Guevara H, Heudel PE, Reverdy T, Bazan F, Heinzelmann-Schwarz V, Fehr M, de Castelbajac V, Vaflard P, Crivelli L, Bonadona V, Viassolo V, Buisson A, Golmard L, Rodrigues M, Ray-Coquard I.

Gynecol Oncol. 2019 Nov;155(2):262-269. doi: 10.1016/j.ygyno.2019.09.008. Epub 2019 Oct 8.


Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme.

Varnier R, Le Saux O, Chabaud S, Garin G, Sohier E, Wang Q, Paindavoine S, Pérol D, Baudet C, Attignon V, Pissaloux D, Heudel P, You B, Leyronnas C, Collard O, Trédan O, Bonnin N, Long J, Jacquin JP, Cassier PA, Derbel O, Freyer G, Viari A, Blay JY, Ray-Coquard I.

Eur J Cancer. 2019 Sep;118:156-165. doi: 10.1016/j.ejca.2019.06.017. Epub 2019 Jul 24.


Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.

Labidi-Galy SI, Olivier T, Rodrigues M, Ferraioli D, Derbel O, Bodmer A, Petignat P, Rak B, Chopin N, Tredan O, Heudel PE, Stuckelberger S, Meeus P, Meraldi P, Viassolo V, Ayme A, Chappuis PO, Stern MH, Houdayer C, Stoppa-Lyonnet D, Buisson A, Golmard L, Bonadona V, Ray-Coquard I.

Clin Cancer Res. 2018 Jan 15;24(2):326-333. doi: 10.1158/1078-0432.CCR-17-2136. Epub 2017 Oct 30.


Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort).

Derbel O, Heudel PE, Cropet C, Meeus P, Vaz G, Biron P, Cassier P, Decouvelaere AV, Ranchere-Vince D, Collard O, De Laroche E, Thiesse P, Farsi F, Cellier D, Gilly FN, Blay JY, Ray-Coquard I.

PLoS One. 2017 Feb 3;12(2):e0158406. doi: 10.1371/journal.pone.0158406. eCollection 2017.


Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.

de la Fouchardiere C, Oussaid N, Derbel O, Decaussin-Petrucci M, Fondrevelle ME, Wang Q, Bringuier PP, Bournaud-Salinas C, Peix JL, Lifante JC, Giraudet AL, Lopez J, Borson-Chazot F.

Target Oncol. 2016 Feb;11(1):71-82. doi: 10.1007/s11523-015-0380-y.


Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma.

Bally O, Tassy L, Richioud B, Decouvelaere AV, Blay JY, Derbel O.

Clin Sarcoma Res. 2015 Apr 23;5:12. doi: 10.1186/s13569-014-0018-3. eCollection 2015.


The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors.

Cassier PA, Floquet A, Penel N, Derbel O, Bui N'guyen B, Guastalla JP, Pissaloux D, Treilleux I, Saba CE, Blay JY, Ray-Coquard I.

Ann Oncol. 2014 May;25(5):1074-5. doi: 10.1093/annonc/mdu045. Epub 2014 Mar 20. No abstract available.


The clinician's perspective on sarcoma pathology reporting: impact on treatment decisions?

Blay JY, Derbel O, Ray-Coquard I.

Pathology. 2014 Feb;46(2):121-5. doi: 10.1097/PAT.0000000000000052. Review.


Do our current clinical trial designs help to guide clinical practice?

Blay JY, Derbel O, Ray-Coquard I.

Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e381. Review.


Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery.

Derbel O, Wang Q, Desseigne F, Rivoire M, Meeus P, Peyrat P, Stella M, Martel-Lafay I, Lemaistre AI, de La Fouchardière C.

BMC Cancer. 2013 Apr 23;13:200. doi: 10.1186/1471-2407-13-200.


Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.

Levard A, Derbel O, Méeus P, Ranchère D, Ray-Coquard I, Blay JY, Cassier PA.

BMC Cancer. 2013 Mar 11;13:109. doi: 10.1186/1471-2407-13-109.


Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.

Blay JY, Italiano A, Ray-Coquard I, Le Cesne A, Duffaud F, Rios M, Collard O, Bertucci F, Bompas E, Isambert N, Chaigneau L, Cassier P, Bui B, Decanter G, Derbel O, Coindre JM, Zintl P, Badri N, Penel N.

BMC Cancer. 2013 Feb 6;13:64. doi: 10.1186/1471-2407-13-64.


Concomitant occurrence of pulmonary invasive aspergillosis and Pneumocystis pneumonia during FOLFIRINOX chemotherapy for pancreatic carcinoma.

Péron J, Derbel O, Penet AS, Stella M, Méeus P, Orlandini F, Pérol M, de la Fouchardière C.

Pancreas. 2013 Jan;42(1):178-80. doi: 10.1097/MPA.0b013e31825486f8. No abstract available.


Pazopanib for the treatment of soft-tissue sarcoma.

Heudel P, Cassier P, Derbel O, Dufresne A, Meeus P, Thiesse P, Ranchère-Vince D, Blay JY, Ray-Coquard I.

Clin Pharmacol. 2012;4:65-70. doi: 10.2147/CPAA.S33195. Epub 2012 Oct 26.


An unusual giant cell tumor of the thyroid: case report and review of the literature.

Derbel O, Zrounba P, Chassagne-Clément C, Decouvelaere AV, Orlandini F, Duplomb S, Blay JY, de la Fouchardiere C.

J Clin Endocrinol Metab. 2013 Jan;98(1):1-6. doi: 10.1210/jc.2011-2306. Epub 2012 Nov 16. Review.


Giant-cell tumor of bone, anti-RANKL therapy.

Dufresne A, Derbel O, Cassier P, Vaz G, Decouvelaere AV, Blay JY.

Bonekey Rep. 2012 Sep 5;1:149. doi: 10.1038/bonekey.2012.149. Review.


Unusual adverse event with vandetanib in metastatic medullary thyroid cancer.

Duplomb S, Benoit A, Mechtouff-Cimarelli L, Cho TH, Derbel O, Peix JL, de la Fouchardière C.

J Clin Oncol. 2012 Jan 10;30(2):e21-3. doi: 10.1200/JCO.2011.38.2796. Epub 2011 Dec 12. No abstract available.


Results of combined treatment of anaplastic thyroid carcinoma (ATC).

Derbel O, Limem S, Ségura-Ferlay C, Lifante JC, Carrie C, Peix JL, Borson-Chazot F, Bournaud C, Droz JP, de la Fouchardière C.

BMC Cancer. 2011 Nov 1;11:469. doi: 10.1186/1471-2407-11-469.


A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.

Derbel O, Cannas G, Le QH, Elhamri M, Chelghoum Y, Nicolas-Virelizier E, Nicolini F, Troncy J, Barraco F, Michallet M, Thomas X.

Hematology. 2010 Jun;15(3):125-31. doi: 10.1179/102453309X12583347113654.


Supplemental Content

Loading ...
Support Center